Abstract:A series of new chelating bidentate (SS) alkylimidazole-2-thione-Ru(II)/Os(II) complexes (3ai, 3aii, 3aiii, 3bii/4aiii, 4bi, 4bii), and the tridentate (SNS) pyridine-2,6-diylimidazole-2-thione-Ru(II)/Os(II) complexes (5bi, 5civ/6bi, 6ci, 6civ) in the forms [MII(cym)(L)Cl]PF6 and [MII(cym)(L)]PF6 (M = Ru or Os, cym = η6-p-cymene, and L = heterocyclic derivatives of thiourea) respectively, were successfully synthesized. Spectroscopic and analytical methods were used to characterize the complexes and their ligands. Solid-state single-crystal X-ray diffraction analyses revealed a "piano-stool" geometry around the Ru(II) or Os(II) centers in the respective complexes. The complexes were investigated for in vitro chemotherapeutic activities against human cervical carcinoma (HeLa) and the non-cancerous cell line (Hek293) using the MTT assay. The compounds 3aii, 5civ, 5bi, 4aiii, 6ci, 6civ, and the reference drug, 5-fluorouracil were found to be selective toward the tumor cells; the compounds 3ai, 3aiii, 3bii, 4bi, 4bii, and 6bi, which were found not to be selective between normal and tumor cell lines. The IC50 value of the tridentate half-sandwich complex 5bi (86 ± 9 μM) showed comparable anti-proliferative activity with the referenced commercial anti-cancer drug, 5-fluorouracil (87 ± 15 μM). The pincer (SNS) osmium complexes 6ci (36 ± 10 μM) and 6civ (40 ± 4 μM) were twice as effective as the reference drug 5-fluorouracil at the respective dose concentrations. However, the analogous pincer (SNS) ruthenium complex 5civ was ineffective and did not show anti-proliferative activity, even at a higher concentration of 147 ± 1 μM. These findings imply that the higher stability of the chelating (SS) and the pincer (SNS) ligand architectures in the complexes improves the biological (anti-proliferative) activity of the complexes by reducing the chance of ligand dissociation under physiological conditions. In general, the pincer (SNS) osmium complexes were found to be more cytotoxic than their ruthenium analogues, suggesting that the anti-proliferative activity of the imidazole-2-thione-Ru/Os complexes depends on the ligand's spatial coordination, the nature of the metal center, and the charge of the metal complex ions.

Addition of Ethynylferrocene to Transition-Metal Complexes Containing a Chelating 1,2-Dicarba-closo-dodecaborane-1,2-dichalcogenolate Ligand--in Vitro Cooperativity of a Ruthenium Compound on Cellular Uptake of an Anticancer Drug.

Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp 2 -N/sp 3 -N Donor Ligands to Achieve Improved Anticancer Selectivity

New Potential Anticancer Agent Of Carborane Derivatives: Selective Cellular Interaction And Activity Of Ferrocene-Substituted Dithio-O-Carborane Conjugates

A novel ferrocene-palladium metal complex: synthesis, single crystal structure, in vitro cytotoxicity study and molecular docking

Mixed-valent Diruthenium Half-Sandwich Complex Containing Two Chelating 1,2-Dicarba-closo-dodecaborane-1,2-dithiolate Ligands: Reactivity Toward (Cyclo-C6h10)(oh)cch and PhC(O)CCH

Reactivity of Dinuclear Ruthenium Complex Containing Oneμ-Se2Unit and Two 1,2-Dicarba-closo-dodecaborane-1,2-dithiolate Ligands Toward (Cyclo-C6h10)(oh)c≡ch

Increasing the cytotoxicity of Ru(II) polypyridyl complexes by tuning the electron donating ability of 1,10-phenanthroline ligands

Mixed-Valent Diruthenium Half-Sandwich Complexes Containing Two Chelating 1,2-Dicarba-closo-dodecaborane-1,2-dithiolate Ligands: Reactivity Towards Phenylacetylene, 1,4-Diethynylbenzene, and Ethynylferrocene

Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes

Chemotherapeutic Activities of New η6-p-Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS Ligands

New ferrocene cyclopalladated compounds: synthesis, X-ray single crystal structure and in vitro anticancer activity study

Electrochemical, spectroscopic and theoretical studies of a series of 1,1′-ferrocene dichalcogenido-complexes of rhodium and iridium

Preparation and Structure of Mono- and Binuclear Half-Sandwich Iridium, Ruthenium, and Rhodium Carbene Complexes Containing 1,2-Dichalcogenolao 1,2-Dicarba-closo-dodecaboranes.

Metal-Induced B−H Activation: Addition of Methyl Acetylene Carboxylates to CpRh-, CpIr-, (P-Cymene)ru-, and (P-Cymene)os Half-Sandwich Complexes Containing the Chelating 1,2-Dicarba-closo-dodecaborane- 1,2-Dithiolate Ligand

Diruthenium Half-Sandwich Complexes Containing One Μ-E2(e = S, Se) Unit and Two Chelating 1,2-Dicarba-closo-dodecaborane-1,2-dithiolate Ligands: Reactivity Studies with Methyl Acetylene Carboxylates

Synthesis and Structure of Heterometallic Complexes (rhfe, CoFe) Containing Bridging 1,2-Dicarba-closo-dodecarborane-1,2-dichalcogenolato Ligands.

Fortuitous synthesis of unsaturated half-sandwich Ruthenium(II) complexes via solvent-involved rearrangement and their biological evaluation

Ligand-Based Neutral Ruthenium(Ii) Arene Complex: Selective Anticancer Action

Diruthenium complexes incorporating carboxylated chalcones with phenyl or ferrocenyl units: Synthesis, structural, electrochemical and DNA binding studies

Synthesis and Characterization of Heterometallic M-Ru (M = Co, Rh, Ir) Clusters Containing the Nido-Dicarborane-1,2-dithiolato Chelating Ligand.

Metal-Induced B−H Activation: Addition of Acetylene, Propyne, or 3-Methoxypropyne to Rh(Cp), Ir(Cp), Ru(p-cymene), and Os(p-cymene) Half-Sandwich Complexes Containing a Chelating 1,2-Dicarba-closo-dodecaborane-1,2-dichalcogenolato Ligand